Heriberto Prado-Garcı́a

2.1k total citations
47 papers, 1.5k citations indexed

About

Heriberto Prado-Garcı́a is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Heriberto Prado-Garcı́a has authored 47 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 18 papers in Oncology and 17 papers in Immunology. Recurrent topics in Heriberto Prado-Garcı́a's work include Cancer Immunotherapy and Biomarkers (9 papers), Immunotherapy and Immune Responses (8 papers) and Cancer Cells and Metastasis (5 papers). Heriberto Prado-Garcı́a is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Immunotherapy and Immune Responses (8 papers) and Cancer Cells and Metastasis (5 papers). Heriberto Prado-Garcı́a collaborates with scholars based in Mexico, Bangladesh and Vietnam. Heriberto Prado-Garcı́a's co-authors include Susana Romero‐Garcia, José Sullivan López-González, Dolores Aguilar‐Cázares, María Maximina Bertha Moreno‐Altamirano, Francisco Javier Sánchez‐García, Ángeles Carlos‐Reyes, Juan José Mandoki, Manuel Meneses-Flores, Mariana Segovia‐Mendoza and Juan Molina-Güarneros and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Heriberto Prado-Garcı́a

46 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Heriberto Prado-Garcı́a Mexico	19	757	445	405	355	200	47	1.5k
Feifei Xu China	24	1.2k 1.5×	352 0.8×	362 0.9×	395 1.1×	132 0.7×	76	1.8k
Xiangsheng Zuo United States	23	1.3k 1.7×	602 1.4×	650 1.6×	274 0.8×	159 0.8×	41	2.2k
Shu‐Xiang Cui China	24	1.0k 1.4×	546 1.2×	428 1.1×	299 0.8×	105 0.5×	69	1.8k
José Sullivan López-González Mexico	19	793 1.0×	382 0.9×	370 0.9×	338 1.0×	144 0.7×	45	1.6k
Francesca Tosetti Italy	23	1.1k 1.4×	339 0.8×	502 1.2×	397 1.1×	124 0.6×	48	2.0k
Zahra Asadzadeh Iran	23	668 0.9×	320 0.7×	573 1.4×	458 1.3×	140 0.7×	45	1.7k
Wioletta Olejarz Poland	19	753 1.0×	418 0.9×	185 0.5×	246 0.7×	120 0.6×	44	1.3k
Naoyo Nishida Japan	12	837 1.1×	366 0.8×	401 1.0×	150 0.4×	140 0.7×	27	1.5k
Feng‐Hou Gao China	23	886 1.2×	253 0.6×	346 0.9×	191 0.5×	117 0.6×	50	1.4k
Arash Soltani Iran	18	539 0.7×	227 0.5×	451 1.1×	332 0.9×	155 0.8×	32	1.3k

Countries citing papers authored by Heriberto Prado-Garcı́a

Since Specialization

Citations

This map shows the geographic impact of Heriberto Prado-Garcı́a's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heriberto Prado-Garcı́a with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heriberto Prado-Garcı́a more than expected).

Fields of papers citing papers by Heriberto Prado-Garcı́a

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heriberto Prado-Garcı́a. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heriberto Prado-Garcı́a. The network helps show where Heriberto Prado-Garcı́a may publish in the future.

Co-authorship network of co-authors of Heriberto Prado-Garcı́a

This figure shows the co-authorship network connecting the top 25 collaborators of Heriberto Prado-Garcı́a. A scholar is included among the top collaborators of Heriberto Prado-Garcı́a based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heriberto Prado-Garcı́a. Heriberto Prado-Garcı́a is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pérez, Lourdes, Selene Lagunas‐Rivera, Marco A. García‐Revilla, et al.. (2024). Novel N-quaternary coumarin-3-yl-imidazo[1,2-a]pyridines as fluorescent hybrids: Their synthesis and biological evaluation in cancer cells. Results in Chemistry. 13. 101959–101959. 2 indexed citations

Carlos‐Reyes, Ángeles, Susana Romero‐Garcia, & Heriberto Prado-Garcı́a. (2024). Metabolic Responses of Lung Adenocarcinoma Cells to Survive under Stressful Conditions Associated with Tumor Microenvironment. Metabolites. 14(2). 103–103. 4 indexed citations

Prado-Garcı́a, Heriberto, et al.. (2024). Intratumoral Heterogeneity and Metabolic Cross-Feeding in a Three-Dimensional Breast Cancer Culture: An In Silico Perspective. International Journal of Molecular Sciences. 25(20). 10894–10894.

Franco-Molina, Moisés Ármides, et al.. (2024). β-D-Glucose-Reduced Silver Nanoparticles Remodel the Tumor Microenvironment in a Murine Model of Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 25(15). 8432–8432. 3 indexed citations

Dı́az, Lorenza, Euclides Avila, Rocio Garcı́a-Becerra, et al.. (2023). The Phytochemical α-Mangostin Inhibits Cervical Cancer Cell Proliferation and Tumor Growth by Downregulating E6/E7-HPV Oncogenes and KCNH1 Gene Expression. International Journal of Molecular Sciences. 24(3). 3055–3055. 18 indexed citations

Ramírez–García, Gonzalo, J. Óscar C. Jiménez‐Halla, Mariana Segovia‐Mendoza, et al.. (2023). A rollover Ir(iii) complex of 2-(6-bromopyridin-2-yl)imidazo[1,2-a]pyridine. New Journal of Chemistry. 47(12). 5625–5633. 2 indexed citations

Segovia‐Mendoza, Mariana, et al.. (2022). The Interplay of GPER1 with 17β-Aminoestrogens in the Regulation of the Proliferation of Cervical and Breast Cancer Cells: A Pharmacological Approach. International Journal of Environmental Research and Public Health. 19(19). 12361–12361. 5 indexed citations

Prado-Garcı́a, Heriberto, et al.. (2022). Histone deacetylases modulate resistance to the therapy in lung cancer. Frontiers in Genetics. 13. 960263–960263. 22 indexed citations

Carlos‐Reyes, Ángeles, et al.. (2022). Role of Circular RNAs in the Regulation of Immune Cells in Response to Cancer Therapies. Frontiers in Genetics. 13. 823238–823238. 12 indexed citations

10.

Pérez‐Hernández, Nury, et al.. (2021). Obtaining symmetric and asymmetric bisphosphoramidates and bisphosphoramidothioates by a single step multicomponent reaction. Phosphorus, sulfur, and silicon and the related elements. 196(7). 634–642. 1 indexed citations

11.

García‐Quiroz, Janice, Rocio Garcı́a-Becerra, Clara Santos‐Cuevas, et al.. (2021). Antitumoral effects of dovitinib in triple-negative breast cancer are synergized by calcitriol in vivo and in vitro. The Journal of Steroid Biochemistry and Molecular Biology. 214. 105979–105979. 10 indexed citations

12.

Romero‐Garcia, Susana, et al.. (2019). Lactic Acidosis Promotes Mitochondrial Biogenesis in Lung Adenocarcinoma Cells, Supporting Proliferation Under Normoxia or Survival Under Hypoxia. Frontiers in Oncology. 9. 1053–1053. 20 indexed citations

13.

Segovia‐Mendoza, Mariana, et al.. (2015). Antihormonal agents as a strategy to improve the effect of chemo-radiation in cervical cancer: in vitro and in vivo study. BMC Cancer. 15(1). 21–21. 23 indexed citations

14.

Segovia‐Mendoza, Mariana, Lorenza Dı́az, Janice García‐Quiroz, et al.. (2014). Calcitriol and its analogues enhance the antiproliferative activity of gefitinib in breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 148. 122–131. 43 indexed citations

15.

Aguilar‐Cázares, Dolores, et al.. (2012). Participación de los patrones moleculares asociados al daño en el tratamiento convencional del cáncer. Revista de investigaci�n Cl�nica. 64(3). 275–283. 1 indexed citations

16.

Romero‐Garcia, Susana, et al.. (2011). Tumor cell metabolism. Cancer Biology & Therapy. 12(11). 939–948. 186 indexed citations

17.

Prado-Garcı́a, Heriberto, et al.. (2007). Lung carcinomas do not induce T-cell apoptosis via the Fas/Fas ligand pathway but down-regulate CD3 epsilon expression. Cancer Immunology Immunotherapy. 57(3). 325–336. 17 indexed citations

18.

López-González, José Sullivan, Federico Ávila‐Moreno, Heriberto Prado-Garcı́a, et al.. (2006). Lung carcinomas decrease the number of monocytes/macrophages (CD14+ cells) that produce TNF-α. Clinical Immunology. 122(3). 323–329. 18 indexed citations

19.

López-González, José Sullivan, et al.. (2004). Apoptosis and cell cycle disturbances induced by coumarin and 7-hydroxycoumarin on human lung carcinoma cell lines. Lung Cancer. 43(3). 275–283. 108 indexed citations

20.

López-González, José Sullivan, Dolores Aguilar‐Cázares, Heriberto Prado-Garcı́a, et al.. (2002). Lack of correlation between growth inhibition by TGF-β and the percentage of cells expressing type II TGF-β receptor in human non-small cell lung carcinoma cell lines. Lung Cancer. 38(2). 149–158. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact